Barry Canton is > 10% Shareholder of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 12.4 Million shares of DNA, which is worth approximately $77.1 Million. The most recent transaction as insider was on Dec 21, 2023, when has been sold 37,650 shares (Class A Common Stock) at a price of $1.74 per share, resulting in proceeds of $65,511. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.4M
0% 3M change
4.36% 12M change
Total Value Held $77.1 Million

Barry Canton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 21 2023
SELL
Open market or private sale
$65,511 $1.74 p/Share
37,650 Reduced 0.3%
12,374,544 Class A Common Stock
Dec 14 2023
SELL
Open market or private sale
$61,369 $1.63 p/Share
37,650 Reduced 0.3%
12,412,194 Class A Common Stock
Dec 12 2023
SELL
Bona fide gift
-
200,000 Reduced 1.58%
12,449,844 Class A Common Stock
Dec 08 2023
BUY
Conversion of derivative security
-
200,000 Added 1.56%
12,649,844 Class A Common Stock
Dec 07 2023
SELL
Open market or private sale
$49,321 $1.31 p/Share
37,650 Reduced 0.3%
12,449,844 Class A Common Stock
Nov 30 2023
SELL
Open market or private sale
$50,827 $1.35 p/Share
37,650 Reduced 0.3%
12,487,494 Class A Common Stock
Nov 24 2023
SELL
Open market or private sale
$53,463 $1.42 p/Share
37,650 Reduced 0.3%
12,525,144 Class A Common Stock
Nov 16 2023
SELL
Open market or private sale
$54,592 $1.45 p/Share
37,650 Reduced 0.3%
12,562,794 Class A Common Stock
Nov 09 2023
SELL
Open market or private sale
$48,568 $1.29 p/Share
37,650 Reduced 0.3%
12,600,444 Class A Common Stock
Nov 02 2023
SELL
Open market or private sale
$57,228 $1.52 p/Share
37,650 Reduced 0.3%
12,638,094 Class A Common Stock
Oct 26 2023
SELL
Open market or private sale
$54,969 $1.46 p/Share
37,650 Reduced 0.3%
12,675,744 Class A Common Stock
Oct 19 2023
SELL
Open market or private sale
$60,616 $1.61 p/Share
37,650 Reduced 0.3%
12,713,394 Class A Common Stock
Oct 12 2023
SELL
Open market or private sale
$62,499 $1.66 p/Share
37,650 Reduced 0.29%
12,751,044 Class A Common Stock
Oct 05 2023
SELL
Open market or private sale
$62,875 $1.67 p/Share
37,650 Reduced 0.29%
12,788,694 Class A Common Stock
Sep 28 2023
SELL
Open market or private sale
$65,887 $1.75 p/Share
37,650 Reduced 0.29%
12,826,344 Class A Common Stock
Sep 21 2023
SELL
Open market or private sale
$66,264 $1.76 p/Share
37,650 Reduced 0.29%
12,863,994 Class A Common Stock
Sep 14 2023
SELL
Open market or private sale
$75,300 $2.0 p/Share
37,650 Reduced 0.29%
12,901,644 Class A Common Stock
Sep 07 2023
SELL
Open market or private sale
$80,194 $2.13 p/Share
37,650 Reduced 0.29%
12,939,294 Class A Common Stock
Aug 31 2023
SELL
Open market or private sale
$86,218 $2.29 p/Share
37,650 Reduced 0.29%
12,976,944 Class A Common Stock
Aug 24 2023
SELL
Open market or private sale
$64,005 $1.7 p/Share
37,650 Reduced 0.29%
13,014,594 Class A Common Stock
Aug 17 2023
SELL
Open market or private sale
$61,745 $1.64 p/Share
37,650 Reduced 0.29%
13,052,244 Class A Common Stock
Aug 10 2023
SELL
Open market or private sale
$66,640 $1.77 p/Share
37,650 Reduced 0.29%
13,089,894 Class A Common Stock
Aug 03 2023
SELL
Open market or private sale
$76,806 $2.04 p/Share
37,650 Reduced 0.29%
13,127,544 Class A Common Stock
Jul 27 2023
SELL
Open market or private sale
$88,477 $2.35 p/Share
37,650 Reduced 0.29%
13,165,194 Class A Common Stock
Jul 20 2023
SELL
Open market or private sale
$85,841 $2.28 p/Share
37,650 Reduced 0.28%
13,202,844 Class A Common Stock
BC

Barry Canton

> 10% Shareholder
Boston, MA

Track Institutional and Insider Activities on DNA

Follow Ginkgo Bioworks Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA